ROCHESTER, N.Y.--(BUSINESS WIRE)--Jan. 10, 2006--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation medical technology, announced today that one U.S. Patent has issued to the Company, and one U.S. patent has issued to one of our licensors who has granted Biophan exclusive worldwide medical rights. These newly issued patents result in Biophan holding or licensing 48 issued patents, 7 allowed applications that will issue as patents in the near future, 102 US applications in prosecution, and a total of 56 foreign counterparts in various stages of prosecution.
